Barts and The London School of Medicine and Dentistry
The aim of this programme is to train a new generation of physicians and scientists able to successfully transfer neuroscience and pharmacology discoveries from the bench to the bedside. The course emphasizes a true translational approach by teaching basic science in an academic environment, involving you in current research techniques and also offering the opportunity to meet patients suffering from a range of neurological diseases.
The topics covered range from the principles of drug design and development to clinical aspects of the management of major neurological diseases, thus providing specialised training and essential skills for translational research. The clinical component is unique to this course and ties together the scientific, clinical and personal aspects of neurological disease.
This programme will give you a thorough training in the main concepts and methods of translational medicine, with a particular focus on unmet needs in diseases of the nervous system, and will critically discuss the challenges associates with developing better therapies in various diseases. At the end of their studies students will have a detailed knowledge of the drug discovery and development process, and of clinical trial design and methodology and also a thorough understanding of the regulatory environment.
The formal teaching includes lectures, seminars, clinical workshops and a research project. Our lecturers are specialists in their field and are well-known pre-clinical scientists and expert clinicians. There are also invited speakers – leading researchers from other UK or international academic institutions and senior scientists from the pharmaceutical industry and the research councils.
This programme will:
- Provide a thorough grounding in the principles underlying translational medicine
- Focus on diseases of the nervous system and the challenges associated with developing better therapies
- Discuss in detail laboratory methods and models used in drug discovery and the specific methodology of clinical trials
- Provide an explanation of the steps involved in the development and implementation of new treatments and how to apply this knowledge in a future professional role
Why study Neuroscience and Translational Medicine at Queen Mary University of London?
Barts and the London School of Medicine and Dentistry is comprised of two world renowned teaching hospitals, St Bartholomew’s and The Royal London, which have made, and continue to make, an outstanding contribution to modern medicine. We were one of the top five institutions in the UK for medicine in the 2014 Research Assessment Exercise.
- At the end of these studies students will have a detailed knowledge of the drug discovery and development process, and of clinical trial design and methodology and the regulatory environment, and this will enhance future career choices and opportunities
- There is still a huge unmet need for new and better treatments for neurological disease. This programme provides a thorough training in the main concepts and methods of translational medicine, and also has a particular focus on unmet needs in diseases of the nervous system and the challenge of developing better therapies
- We have a large number of specialists teaching on the course, and many are world leaders in their fields. These include academics from other institutions, clinicians, and specialists from the pharmaceutical industry.
For more information about intercalation please visit the Barts and The London School of Medicine and Dentistry website.
- Successfully completed at least 3 years of the MBBS, MbChB or equivalent medical course
- (for clinically based Masters this must include the equivalent of one year of patient based teaching (in hospital/GP practices/clinics)).
- Passed year 3 or 4 exams immediately prior to entry at the first opportunity.
- Demonstrate a clear and unequivocal interest in the field by written application +/- interview.
- For students internal and external to QMUL it is confirmed that the beginning of the first term for the following year starts after all the QMUL Masters assessments are completed.
Wednesday 27 August 2022